Where is arteriosclerosis obliterans treated well?

summary

Arteriosclerosis obliterans is a common disease in our life. Many patients do not know where to go for treatment. In fact, there are many places for treatment. The first choice for elderly patients with arteriosclerosis obliterans is some hospitals specialized in traditional Chinese medicine. Many people are not very interested in traditional Chinese medicine, Moreover, some prevention methods for patients with this disease are also wrong, so after a long time, it may cause the disease to become more and more serious. The disease has little interference on the body, but the biggest harm is that the disease will damage some normal organs in the body, and gradually become serious over time

Where is arteriosclerosis obliterans treated well?

First: arteriosclerosis is a systemic disease that can occur in all parts of the body. The more common is arteriosclerosis obliterans of the lower limbs, the patient's ability to move will be affected. In fact, this kind of disease is likely to be cured. The general treatment methods are as follows.

Second, the most direct method is to carry out surgical treatment, reconstruct the arterial blood flow channel, and timely improve the problem of insufficient blood supply. For example: arterial bypass, endarterectomy and other surgical methods can improve the patient's vascular disease problems, enhance the patient's tolerance

Third: in addition to surgical treatment, there is also minimally invasive treatment, this way of risk will be relatively low, the patient's later recovery will be better. For example, stent implantation, through the expansion of the artery lumen to achieve good surgical results, is one of the first choice of treatment.

matters needing attention

The preventive medicine of this disease should pay attention to the strict monitoring of blood pressure, blood glucose and blood lipid. And to quit smoking immediately, so as to delay atherosclerosis, and prevent the occurrence of cardiovascular and cerebrovascular adverse events